LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 105.425 USD -1.55%
Market Cap: 2.4B USD
Have any thoughts about
LeMaitre Vascular Inc?
Write Note

LeMaitre Vascular Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LeMaitre Vascular Inc
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
LeMaitre Vascular Inc
NASDAQ:LMAT
Stock-Based Compensation
$6.2m
CAGR 3-Years
23%
CAGR 5-Years
19%
CAGR 10-Years
17%
Becton Dickinson and Co
NYSE:BDX
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Stock-Based Compensation
$676m
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LeMaitre Vascular Inc
Glance View

Market Cap
2.4B USD
Industry
Health Care

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

LMAT Intrinsic Value
54.085 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is LeMaitre Vascular Inc's Stock-Based Compensation?
Stock-Based Compensation
6.2m USD

Based on the financial report for Sep 30, 2024, LeMaitre Vascular Inc's Stock-Based Compensation amounts to 6.2m USD.

What is LeMaitre Vascular Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
17%

Over the last year, the Stock-Based Compensation growth was 36%. The average annual Stock-Based Compensation growth rates for LeMaitre Vascular Inc have been 23% over the past three years , 19% over the past five years , and 17% over the past ten years .

Back to Top